SCHEMBL8836352

SCHEMBL8836352

Nc1[nH]nc(-c2ccc(F)cc2)c1-c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
AXL P30530 1/20 0.45
IDO1 P14902 1/20 0.43
LRRK2 Q5S007 1/20 0.43
GPR55 Q9Y2T6 1/20 0.42
CYP19A1 P11511 1/20 0.42
ALDH1A1 P00352 2/20 0.41
NTRK1 P04629 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
PIM1 P11309 3/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
MAPK14 Q16539 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MAPK11 Q15759 1/20 0.40
ALPL P05186 1/20 0.40
MAP2K4 P45985 1/20 0.40
ELOVL1 Q9BW60 1/20 0.39
NPY5R Q15761 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7491106 0.82 MAPK14 (0.59) MAPK14MAPK11
SCHEMBL6177789 0.82 MAPK14 (0.59) MAPK14MAPK11
SCHEMBL1383363 0.77 MAPK14 (0.55) PIM1MAPK14MAP2K4
SCHEMBL8836698 0.77 MAPK14 (0.51) MAPK14MAPK11
SCHEMBL8836677 0.75 TGFBR1 (0.49) LRRK2ALDH1A1NTRK1PIM1MAPK14
SCHEMBL8836207 0.74 MAPK14 (0.59) MAPK14MAPK11
SCHEMBL8836383 0.74 MAPK14 (0.47) IDO1MAPK14MAPK11
SCHEMBL13516379 0.74 CYP2A6 (0.45) KDM4EAXLIDO1LRRK2ALDH1A1
SCHEMBL20837058 0.74 CYP2A6 (0.41) AXLIDO1LRRK2ALDH1A1PIM1
SCHEMBL19926065 0.72 GSK3A (0.57) KDM4EIDO1ALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624931-A Pyrazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-29 US disclosed
US-5478827-A Inhibits Interleukin-1 and tumor necrosis factor production FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-12-26 US disclosed
US-5356897-A Inhibit the production of Interleukin-1 and tumor necrosis factor; administering for treatment of chronic inflammatory diseases, autoimmune diseases and sepsis-induced organ injury FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-10-18 US disclosed
EP-0531901-A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed